366 related articles for article (PubMed ID: 31102185)
61. Rho-kinase inhibitor hydroxyfasudil protects against HIV-1 Tat-induced dysfunction of tight junction and neprilysin/Aβ transfer receptor expression in mouse brain microvessels.
Chen Q; Wu Y; Yu Y; Wei J; Huang W
Mol Cell Biochem; 2021 May; 476(5):2159-2170. PubMed ID: 33548010
[TBL] [Abstract][Full Text] [Related]
62. Potential Tools for Eradicating HIV Reservoirs in the Brain: Development of Trojan Horse Prodrugs for the Inhibition of P-Glycoprotein with Anti-HIV-1 Activity.
Agrawal N; Rowe J; Lan J; Yu Q; Hrycyna CA; Chmielewski J
J Med Chem; 2020 Mar; 63(5):2131-2138. PubMed ID: 31505928
[TBL] [Abstract][Full Text] [Related]
63. Genetic and non-genetic determinants of raltegravir penetration into cerebrospinal fluid: a single arm pharmacokinetic study.
Johnson DH; Sutherland D; Acosta EP; Erdem H; Richardson D; Haas DW
PLoS One; 2013; 8(12):e82672. PubMed ID: 24349334
[TBL] [Abstract][Full Text] [Related]
64. Abacavir/lamivudine/dolutegravir single tablet regimen in patients with human immunodeficiency virus and end-stage renal disease on hemodialysis.
Michienzi SM; Schriever CA; Badowski ME
Int J STD AIDS; 2019 Feb; 30(2):181-187. PubMed ID: 30381029
[TBL] [Abstract][Full Text] [Related]
65. PPAR agonist-mediated protection against HIV Tat-induced cerebrovascular toxicity is enhanced in MMP-9-deficient mice.
Huang W; Chen L; Zhang B; Park M; Toborek M
J Cereb Blood Flow Metab; 2014 Apr; 34(4):646-53. PubMed ID: 24424383
[TBL] [Abstract][Full Text] [Related]
66. Differential Mechanisms of Inflammation and Endothelial Dysfunction by HIV-1 Subtype-B and Recombinant CRF02_AG Tat Proteins on Human Brain Microvascular Endothelial Cells: Implications for Viral Neuropathogenesis.
Bhargavan B; Kanmogne GD
Mol Neurobiol; 2018 Feb; 55(2):1352-1363. PubMed ID: 28127697
[TBL] [Abstract][Full Text] [Related]
67. Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism.
Slosky LM; Thompson BJ; Sanchez-Covarrubias L; Zhang Y; Laracuente ML; Vanderah TW; Ronaldson PT; Davis TP
Mol Pharmacol; 2013 Nov; 84(5):774-86. PubMed ID: 24019224
[TBL] [Abstract][Full Text] [Related]
68. Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.
Walmsley SL; Antela A; Clumeck N; Duiculescu D; Eberhard A; Gutiérrez F; Hocqueloux L; Maggiolo F; Sandkovsky U; Granier C; Pappa K; Wynne B; Min S; Nichols G;
N Engl J Med; 2013 Nov; 369(19):1807-18. PubMed ID: 24195548
[TBL] [Abstract][Full Text] [Related]
69. CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.
Gonek M; McLane VD; Stevens DL; Lippold K; Akbarali HI; Knapp PE; Dewey WL; Hauser KF; Paris JJ
Brain Behav Immun; 2018 Mar; 69():124-138. PubMed ID: 29146238
[TBL] [Abstract][Full Text] [Related]
70. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.
Bourasset F; Cisternino S; Temsamani J; Scherrmann JM
J Neurochem; 2003 Sep; 86(6):1564-7. PubMed ID: 12950465
[TBL] [Abstract][Full Text] [Related]
71. HIV-1 Tat triggers nuclear localization of ZO-1 via Rho signaling and cAMP response element-binding protein activation.
Zhong Y; Zhang B; Eum SY; Toborek M
J Neurosci; 2012 Jan; 32(1):143-50. PubMed ID: 22219277
[TBL] [Abstract][Full Text] [Related]
72. Enhanced autophagy in pulmonary endothelial cells on exposure to HIV-Tat and morphine: Role in HIV-related pulmonary arterial hypertension.
Dalvi P; Sharma H; Chinnappan M; Sanderson M; Allen J; Zeng R; Choi A; O'Brien-Ladner A; Dhillon NK
Autophagy; 2016 Dec; 12(12):2420-2438. PubMed ID: 27723373
[TBL] [Abstract][Full Text] [Related]
73. Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior.
Hahn YK; Podhaizer EM; Farris SP; Miles MF; Hauser KF; Knapp PE
Brain Struct Funct; 2015 Mar; 220(2):605-23. PubMed ID: 24352707
[TBL] [Abstract][Full Text] [Related]
74. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
[TBL] [Abstract][Full Text] [Related]
75. Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum.
Theodore S; Cass WA; Maragos WF
Exp Neurol; 2006 Jun; 199(2):490-8. PubMed ID: 16510141
[TBL] [Abstract][Full Text] [Related]
76. Intact lipid rafts regulate HIV-1 Tat protein-induced activation of the Rho signaling and upregulation of P-glycoprotein in brain endothelial cells.
Zhong Y; Hennig B; Toborek M
J Cereb Blood Flow Metab; 2010 Mar; 30(3):522-33. PubMed ID: 19794400
[TBL] [Abstract][Full Text] [Related]
77. Sensitization of enteric neurons to morphine by HIV-1 Tat protein.
Fitting S; Ngwainmbi J; Kang M; Khan FA; Stevens DL; Dewey WL; Knapp PE; Hauser KF; Akbarali HI
Neurogastroenterol Motil; 2015 Apr; 27(4):468-80. PubMed ID: 25703354
[TBL] [Abstract][Full Text] [Related]
78. HIV-1 Tat Induces Dysregulation of PGC1-Alpha and Sirtuin 3 Expression in Neurons: The Role of Mitochondrial Biogenesis in HIV-Associated Neurocognitive Disorder (HAND).
Figarola-Centurión I; Escoto-Delgadillo M; González-Enríquez GV; Gutiérrez-Sevilla JE; Vázquez-Valls E; Cárdenas-Bedoya J; Torres-Mendoza BM
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139395
[TBL] [Abstract][Full Text] [Related]
79. The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration.
Fields JA; Metcalf J; Overk C; Adame A; Spencer B; Wrasidlo W; Florio J; Rockenstein E; He JJ; Masliah E
J Neurovirol; 2017 Apr; 23(2):290-303. PubMed ID: 28105557
[TBL] [Abstract][Full Text] [Related]
80. Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir.
Lanzafame M; Nicole S; Rizzardo S; Piacentini D; Chiesi S; Lattuada E; Diani E; Carelli M; Vento S; Gibellini D
New Microbiol; 2018 Oct; 41(4):262-267. PubMed ID: 30311623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
